ID NOW COVID-19 ASSAY
Report
- Report Number
- 1221359-2021-01566
- Event Type
- Injury
- Date Received
- May 26, 2021
- Date of Event
- April 26, 2021
- Report Date
- August 17, 2021
- Manufacturer
- ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
- Product Code
- QJR
- UDI-DI
- 10811877011320
- PMA / PMN Number
- EUA2000074
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- OTHER
Narratives
TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 1022562 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 191-000 / LOT: 1022562, TEST BASE PART NUMBER 130-430 / LOT: 1020562 THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 1022562 SHOWED THAT THE COMPLAINT RATE IS 0.008%. ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE, HOWEVER A POSSIBLE ASSIGNABLE ROOT CAUSE IS SAMPLE INTERFERENCE.
REFERENCE MFR. REPORT : 1221359-2021-01563 ( PATIENT 1), 1221359-2021-01564 ( PATIENT 2), 1221359-2021-01565 ( PATIENT 3). THE INVESTIGATION IS STILL IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.
THE CUSTOMER REPORTED FOUR FALSE NEGATIVE RESULTS WITH THE ID NOW COVID-19 ASSAY. THIS MFR. REPORT ADDRESSES PATIENT FOUR OF FOUR. THE CUSTOMER REPORTED A FALSE NEGATIVE RESULT WITH THE ID NOW COVID -19 ASSAY PERFORMED ON (B)(6) 2021 ON A NASOPHARYNGEAL SWAB IN VIRAL TRANSPORT MEDIA ( CITOTEST LABWARE). REPEATING TESTING WAS PERFORMED ON THE ID NOW GENERATED POSITIVE RESULT . PCR CONFIRMATION TESTING ON CEPHEID GENEXPERT PLATFORM GENERATED POSITIVE RESULTS. ( CT VALUE : 25( GENE N2) AND 22 ( GENE E) ) . THE CUSTOMER STATED THE PATIENT WAS SYMPTOMATIC WITH SYMPTOMS RESPIRATORY SYMPTOMS. THE CUSTOMER CONFIRMED THE PATIENT'S MEDICATION LIST ( LOXEN 50MG, PLAVIX 75MG, DIFFU K 1/J, LASILIX 40MG, DÉBRIDAT 200MG, LOXEN 20MG 1/J). PER THE CUSTOMER, THE PATIENT WAS HOSPITALIZED IN THE COVID-19 DEPARTMENT WITH PNEUMOPATHIE AND WAS CURED (B)(6) 2021. THE CUSTOMER ALSO REPORTED THE PATIENT'S COVID-19 CARE WAS DELAYED; HOWEVER, NO PATIENT HARM OCCURRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 780535 | ID NOW COVID-19 ASSAY | MOLECULAR IVD FOR ID NOW COVID-19 | QJR | ABBOTT DIAGNOSTICS SCARBOROUGH, INC. | 1022562 | 10811877011320 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Other |